Cargando…

Repurposing Penfluridol in Combination with Temozolomide for the Treatment of Glioblastoma

Despite the presence of aggressive treatment strategies, glioblastoma remains intractable, warranting a novel therapeutic modality. An oral antipsychotic agent, penflurido (PFD), used for schizophrenia treatment, has shown an antitumor effect on various types of cancer cells. As glioma sphere-formin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Hyungsin, Chong, Kyuha, Ryu, Byung-Kyu, Park, Kyung-Jae, Yu, Mi OK, Lee, Jihye, Chung, Seok, Choi, Seongkyun, Park, Myung-Jin, Chung, Yong-Gu, Kang, Shin-Hyuk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770574/ https://www.ncbi.nlm.nih.gov/pubmed/31492002 http://dx.doi.org/10.3390/cancers11091310

Ejemplares similares

Penfluridol as a Candidate of Drug Repurposing for Anticancer Agent
por: Tuan, Nguyen Minh, et al.
Publicado: (2019)

Drug repurposing: Antimicrobial and antibiofilm effects of penfluridol against Enterococcus faecalis
por: Zeng, Xianghai, et al.
Publicado: (2020)

Immune consequences of penfluridol treatment associated with inhibition of glioblastoma tumor growth
por: Ranjan, Alok, et al.
Publicado: (2017)

Penfluridol suppresses glioblastoma tumor growth by Akt-mediated inhibition of GLI1
por: Ranjan, Alok, et al.
Publicado: (2017)

Synergistic Tumor Inhibition via Energy Elimination by Repurposing Penfluridol and 2-Deoxy-D-Glucose in Lung Cancer
por: Lai, Tsung-Ching, et al.
Publicado: (2022)

PENFLURIDOL MAINTENANCE THERAPY IN SCHIZOPHRENIA: A CONTROLLED STUDY
por: Channabasavanna, S.M., et al.
Publicado: (1987)

Penfluridol overcomes paclitaxel resistance in metastatic breast cancer
por: Gupta, Nehal, et al.
Publicado: (2019)

Low Dose of Penfluridol Inhibits VEGF-Induced Angiogenesis
por: Srivastava, Suyash, et al.
Publicado: (2020)

Penfluridol suppresses pancreatic tumor growth by autophagy-mediated apoptosis
por: Ranjan, Alok, et al.
Publicado: (2016)

Concurrent Chemoradiotherapy with Temozolomide Followed by Adjuvant Temozolomide for Newly Diagnosed Glioblastoma Patients: A Retrospective Multicenter Observation Study in Korea
por: Kim, Byung Sup, et al.
Publicado: (2017)

Novel cancer stem cell marker MVP enhances temozolomide-resistance in glioblastoma
por: Noh, Kum Hee, et al.
Publicado: (2021)

Antimicrobial, Antibiofilm, and Anti-persister Activities of Penfluridol Against Staphylococcus aureus
por: Liu, Yaqian, et al.
Publicado: (2021)

One-Year Outcome of Multiple Blood–Brain Barrier Disruptions With Temozolomide for the Treatment of Glioblastoma
por: Park, So Hee, et al.
Publicado: (2020)

Gossypol Suppresses Growth of Temozolomide-Resistant Glioblastoma Tumor Spheres
por: Kim, Hee Yeon, et al.
Publicado: (2019)

Combined effects of niclosamide and temozolomide against human glioblastoma tumorspheres
por: Oh, Hyeong-Cheol, et al.
Publicado: (2020)

Long-term outcomes of concomitant chemoradiotherapy with temozolomide for newly diagnosed glioblastoma patients: A single-center analysis
por: Roh, Tae Hoon, et al.
Publicado: (2017)

Association between survival and levetiracetam use in glioblastoma patients treated with temozolomide chemoradiotherapy
por: Roh, Tae Hoon, et al.
Publicado: (2020)

Temozolomide resistance in glioblastoma multiforme
por: Lee, Sang Y.
Publicado: (2016)

Penfluridol targets acid sphingomyelinase to inhibit TNF signaling and is therapeutic against inflammatory autoimmune diseases
por: Chen, Yue-hong, et al.
Publicado: (2022)

Inhibition of AMPK/PFKFB3 mediated glycolysis synergizes with penfluridol to suppress gallbladder cancer growth
por: Hu, Jiahao, et al.
Publicado: (2022)

Restoration of miR-29b exerts anti-cancer effects on glioblastoma
por: Shin, Jaekyung, et al.
Publicado: (2017)

Tumor Microenvironment and Genes Affecting the Prognosis of Temozolomide-Treated Glioblastoma
por: Jang, Yena, et al.
Publicado: (2023)

Impact of glycemia on survival of glioblastoma patients treated with radiation and temozolomide
por: Tieu, Minh Thi, et al.
Publicado: (2015)

Accelerated hyperfractionation plus temozolomide in glioblastoma
por: Kaul, David, et al.
Publicado: (2016)

Strategies of temozolomide in future glioblastoma treatment
por: Lee, Chooi Yeng
Publicado: (2017)

Temozolomide antagonizes oncolytic immunovirotherapy in glioblastoma
por: Saha, Dipongkor, et al.
Publicado: (2020)

A phase Ib/IIa trial of 9 repurposed drugs combined with temozolomide for the treatment of recurrent glioblastoma: CUSP9v3
por: Halatsch, Marc-Eric, et al.
Publicado: (2021)

Combination Therapy for Gliomas Using Temozolomide and Interferon-Beta Secreting Human Bone Marrow Derived Mesenchymal Stem Cells
por: Park, Jae-Hyun, et al.
Publicado: (2015)

Combinatorial Therapeutic Effect of Inhibitors of Aldehyde Dehydrogenase and Mitochondrial Complex I, and the Chemotherapeutic Drug, Temozolomide against Glioblastoma Tumorspheres
por: Park, Hun Ho, et al.
Publicado: (2021)

Temozolomide Treatment Increases Fatty Acid Uptake in Glioblastoma Stem Cells
por: Caragher, Seamus, et al.
Publicado: (2020)

Autophagosome accumulation-mediated ATP energy deprivation induced by penfluridol triggers nonapoptotic cell death of lung cancer via activating unfolded protein response
por: Hung, Wen-Yueh, et al.
Publicado: (2019)

Polymer–Temozolomide Conjugates as Therapeutics for Treating Glioblastoma
por: Ward, Sarah M., et al.
Publicado: (2018)

Potential Strategies Overcoming the Temozolomide Resistance for Glioblastoma
por: JIAPAER, Shabierjiang, et al.
Publicado: (2018)

Dovitinib enhances temozolomide efficacy in glioblastoma cells
por: Thanasupawat, Thatchawan, et al.
Publicado: (2017)

Considering the Experimental Use of Temozolomide in Glioblastoma Research
por: Herbener, Verena J., et al.
Publicado: (2020)

Temozolomide and Other Alkylating Agents in Glioblastoma Therapy
por: Strobel, Hannah, et al.
Publicado: (2019)

On optimal temozolomide scheduling for slowly growing glioblastomas
por: Segura-Collar, Berta, et al.
Publicado: (2022)

XAF1 directs glioma response to temozolomide through apoptotic transition of autophagy by activation of ATM–AMPK signaling
por: Lee, Min-Goo, et al.
Publicado: (2022)

HOXA10 is associated with temozolomide resistance through regulation of the homologous recombinant DNA repair pathway in glioblastoma cell lines
por: Kim, Jin Wook, et al.
Publicado: (2014)

Ibudilast sensitizes glioblastoma to temozolomide by targeting Macrophage Migration Inhibitory Factor (MIF)
por: Ha, Wendy, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_t1g6kr4s3tsiibe16jr0lh3r8p